Review




Structured Review

Peptide Institute cgrp
Cgrp, supplied by Peptide Institute, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/37+8+cgrp/pm12084528-101-36-18
Average 86 stars, based on 1 article reviews
cgrp - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

other:

Article Title: Localization of calcitonin gene-related peptide receptors in rat gastric mucosa.
Article Snippet: The location of calcitonin gene-related peptide (CGRP) receptors in the rat stomach has not been elucidated.. It was recently reported that the CGRP receptor is formed when a calcitonin-receptor-like receptor (CRLR) and receptor activity modifying protein (RAMP) 1 are co-expressed on the cell membrane.. The aim of this study was to determine the location and the role of CGRP receptors in the rat gastric mucosa.



Similar Products

96
Agilent technologies advancebio peptide mapping column
Advancebio Peptide Mapping Column, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/AdvanceBio+Peptide+Mapping/pm42956583-147-11-23
Average 96 stars, based on 1 article reviews
advancebio peptide mapping column - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
InvivoGen peptide m agarose
Peptide M Agarose, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/Peptide+M+Agarose/pm42956746-278-4-7
Average 96 stars, based on 1 article reviews
peptide m agarose - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Cerapedics i-factor peptide enhanced bone graft
I Factor Peptide Enhanced Bone Graft, supplied by Cerapedics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/i+factor+peptide+enhanced+bone+graft/nct05038527-110-10-18
Average 90 stars, based on 1 article reviews
i-factor peptide enhanced bone graft - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
ALPCO human c peptide elisa kit
Human C Peptide Elisa Kit, supplied by ALPCO, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/C-Peptide+ELISA/pm42962661-921-11-15
Average 94 stars, based on 1 article reviews
human c peptide elisa kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

97
InvivoGen ova peptide
Ova Peptide, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/OVA+323-339/pm42998252-265-0-5
Average 97 stars, based on 1 article reviews
ova peptide - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

98
MedChemExpress peptide 740y p
Peptide 740y P, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/740+Y-P/pm42981166-65-2-7
Average 98 stars, based on 1 article reviews
peptide 740y p - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

94
MedChemExpress gip peptide
Gip Peptide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/GIP%2C+human/pm42980901-56-41-45
Average 94 stars, based on 1 article reviews
gip peptide - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
R&D Systems plaqav dpa rsssr nh2 fluorogenic peptide substrate iii
Plaqav Dpa Rsssr Nh2 Fluorogenic Peptide Substrate Iii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/Mca-PLAQAV-Dpa-RSSSR-NH2+Fluorogenic+Peptide+Substrate/pm42979410-90-14-27
Average 94 stars, based on 1 article reviews
plaqav dpa rsssr nh2 fluorogenic peptide substrate iii - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
MedChemExpress peptide antagonist epi x4
(A) CellChat cell-cell communication analysis of chemokine pathways between structural cells and CD8+ T cell states nominated by proportionality analysis in . (B) Dot plot of Cxcl12 and Ccl19 expression scaled by z-score in T2 single-cell timecourse. (C) CXCL12 and CCL19 protein levels in ear skin lysates across primary and secondary MC903. (D) Dot plot of single-cell fibroblast CCL19 expression across healthy (H), AD non-lesional (NL) and AD lesional (L) human skin. (E) Proportion of CXCR4+ cells across immune cell subtypes present in skin on D13 of T2 inflammation (n=18 mice). (F) Ear thickness curve of primary MC903 with treatment by <t>EPI-X4</t> to block CXCR4-mediated recruitment (n=25 mice/condition). EPI-X4 or ethanol vehicle-control treatment days are denoted by arrows. (G) Immune cell representation in D13 skin after EPI-X4 treatment (n=6 mice/condition). (H) Explant schematic and Ccl19 qPCR after 20-hour culture (n=5 explants). (I) Schematic of Transwell CD8+ T cell migration assays to explant-conditioned media with antibody-mediated CCL19 blockade. Migrated CD8+ T cells in the lower chamber were counted by flow cytometry (n=3 explants/condition). (J) Heatmap of Ccl19 expression by primary fibroblasts after Trm-derived cytokine stimulation measured by bulk RNA-seq (n=8 mice/condition). (K) Schematic of TNF-α blockade prior to T2 recall with ELISA measurement of CCL19 levels on D37 in ear skin lysates (n=8 (Iso), 9 (α-TNF-α) mice). (L) One-day ear thickness changes with TNF-α blockade (n=8 mice/condition). (M) Quantification of abundance of NK1.1+ cells and T cells in D37 skin after TNF-α blockade (n=8 mice/condition). (N) Concentration of IL-4 in skin lysates in T2 memory (n=4 mice/timepoint). (O) Left: Schematic illustrating hypothesized interaction between IL-4 and TNF-α signaling in iFBs. Right: qPCR analysis of primary dermal fibroblasts stimulated with IL-4, TNF-α or the combination for 48 hours (n=3 mice/condition).
Peptide Antagonist Epi X4, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/EPI-X4/bio_rxiv__64898__2026__11__02__763646-461-6-9
Average 94 stars, based on 1 article reviews
peptide antagonist epi x4 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


(A) CellChat cell-cell communication analysis of chemokine pathways between structural cells and CD8+ T cell states nominated by proportionality analysis in . (B) Dot plot of Cxcl12 and Ccl19 expression scaled by z-score in T2 single-cell timecourse. (C) CXCL12 and CCL19 protein levels in ear skin lysates across primary and secondary MC903. (D) Dot plot of single-cell fibroblast CCL19 expression across healthy (H), AD non-lesional (NL) and AD lesional (L) human skin. (E) Proportion of CXCR4+ cells across immune cell subtypes present in skin on D13 of T2 inflammation (n=18 mice). (F) Ear thickness curve of primary MC903 with treatment by EPI-X4 to block CXCR4-mediated recruitment (n=25 mice/condition). EPI-X4 or ethanol vehicle-control treatment days are denoted by arrows. (G) Immune cell representation in D13 skin after EPI-X4 treatment (n=6 mice/condition). (H) Explant schematic and Ccl19 qPCR after 20-hour culture (n=5 explants). (I) Schematic of Transwell CD8+ T cell migration assays to explant-conditioned media with antibody-mediated CCL19 blockade. Migrated CD8+ T cells in the lower chamber were counted by flow cytometry (n=3 explants/condition). (J) Heatmap of Ccl19 expression by primary fibroblasts after Trm-derived cytokine stimulation measured by bulk RNA-seq (n=8 mice/condition). (K) Schematic of TNF-α blockade prior to T2 recall with ELISA measurement of CCL19 levels on D37 in ear skin lysates (n=8 (Iso), 9 (α-TNF-α) mice). (L) One-day ear thickness changes with TNF-α blockade (n=8 mice/condition). (M) Quantification of abundance of NK1.1+ cells and T cells in D37 skin after TNF-α blockade (n=8 mice/condition). (N) Concentration of IL-4 in skin lysates in T2 memory (n=4 mice/timepoint). (O) Left: Schematic illustrating hypothesized interaction between IL-4 and TNF-α signaling in iFBs. Right: qPCR analysis of primary dermal fibroblasts stimulated with IL-4, TNF-α or the combination for 48 hours (n=3 mice/condition).

Journal: bioRxiv

Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

doi: 10.64898/2026.11.02.763646

Figure Lengend Snippet: (A) CellChat cell-cell communication analysis of chemokine pathways between structural cells and CD8+ T cell states nominated by proportionality analysis in . (B) Dot plot of Cxcl12 and Ccl19 expression scaled by z-score in T2 single-cell timecourse. (C) CXCL12 and CCL19 protein levels in ear skin lysates across primary and secondary MC903. (D) Dot plot of single-cell fibroblast CCL19 expression across healthy (H), AD non-lesional (NL) and AD lesional (L) human skin. (E) Proportion of CXCR4+ cells across immune cell subtypes present in skin on D13 of T2 inflammation (n=18 mice). (F) Ear thickness curve of primary MC903 with treatment by EPI-X4 to block CXCR4-mediated recruitment (n=25 mice/condition). EPI-X4 or ethanol vehicle-control treatment days are denoted by arrows. (G) Immune cell representation in D13 skin after EPI-X4 treatment (n=6 mice/condition). (H) Explant schematic and Ccl19 qPCR after 20-hour culture (n=5 explants). (I) Schematic of Transwell CD8+ T cell migration assays to explant-conditioned media with antibody-mediated CCL19 blockade. Migrated CD8+ T cells in the lower chamber were counted by flow cytometry (n=3 explants/condition). (J) Heatmap of Ccl19 expression by primary fibroblasts after Trm-derived cytokine stimulation measured by bulk RNA-seq (n=8 mice/condition). (K) Schematic of TNF-α blockade prior to T2 recall with ELISA measurement of CCL19 levels on D37 in ear skin lysates (n=8 (Iso), 9 (α-TNF-α) mice). (L) One-day ear thickness changes with TNF-α blockade (n=8 mice/condition). (M) Quantification of abundance of NK1.1+ cells and T cells in D37 skin after TNF-α blockade (n=8 mice/condition). (N) Concentration of IL-4 in skin lysates in T2 memory (n=4 mice/timepoint). (O) Left: Schematic illustrating hypothesized interaction between IL-4 and TNF-α signaling in iFBs. Right: qPCR analysis of primary dermal fibroblasts stimulated with IL-4, TNF-α or the combination for 48 hours (n=3 mice/condition).

Article Snippet: CXCR4 signaling was inhibited using the peptide antagonist EPI-X4 (MedChemExpress HY-P10415) .

Techniques: Analysis, Expressing, Single Cell, Immune Cell, Blocking Assay, Control, Migration, Flow Cytometry, Derivative Assay, RNA Sequencing, Enzyme-linked Immunosorbent Assay, Concentration Assay, Significance Assay, Gene Expression